Uncategorized

Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis

Immunic, Inc. announced the publication of preclinical data confirming that vidofludimus calcium acts as a potent nuclear receptor related 1 activator, in addition to its known mode of action as a dihydroorotate dehydrogenase inhibitor.

Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis Read More »

Scroll to Top